Cytodyn Inc (CYDY)

[Badge04]

FDA allowing patients that met original CD12 inclusion criteria to be administered the active drug.

It’s a massive tell by the FDA. They wouldn’t allow the open label extension without confidence in the 1. Safety and 2. Outcome measures of CD12 study. It’s a massively important decision prior to unblinding and granting EUA prior to formal FDA approval

I suspect they feel a sense of pressure knowing other countries are going to grant approval. Inventory will be scarce..